SUMMARY Serum amyloid A protein (SAA), apolipoprotein A-I (apoA-I), apolipoprotein B (apoB) concentrations, and creatine kinase (CK)-MB isoenzyme activity were serially measured in 10 patients during the course of acute myocardial infarction. Pronounced increases in SAA concentrations were observed in all patients during infarction. The highest SAA values were observed, on average, 67 hours after the onset ofchest pain. After infarction both apoA-I and apoB concentrations decreased. The reduction in apoA-I concentration 67 to 72 hours after the onset of chest pain was (31 %) (p < 0 01) and the reduction in apoB concentration 55 to 60 hours after the onset of pain was (34%) (p < 0-01). Negative correlations were found between the concentrations of SAA and apoproteins A-I and B; this inverse relation was stronger between SAA and apoB than between SAA and apo-AI.
Serum amyloid A (SAA) is a low molecular weight protein (Mr -12000) which is associated with high density lipoproteins in the circulation. '3 In plasma from normal subjects SAA is present only in trace amounts but in disease states characterised by tissue injury and inflammation the plasma concentration of this acute phase reactant is much increased.'v Macrophage/monocyte-derived interleukin l78 has been shown to be a potent inducer of SAA synthesis in hepatocytes. The mechanism by which interleukin I stimulates the synthesis seems to be a direct modulation of the expression of the genes coding for SAA.9 A recent study suggests that tumour necrosis factor-a may also induce acute phase protein synthesis. ' land) with a turbidometric method using the apoA-I (normal reference range 0-86-1-46 g/l) and apoB (normal reference range 0-92-1 33 g/l) kits (Orion Diagnostica, Espoo, Finland).
CK-MB activity was measured by immunoassay using a kit from Boehringer-Mannheim (Mannheim, Federal Republic of Germany). Paired Student's t-test (two-tailed) and linear regression analysis (after transformation of the data to the natural logarithms) were used.
Results
Significant increases in the plasma SAA concentration occurred in all 10 patients with acute myocardial infarction (fig 1) . The mean peak value of SAA concentration during infarction was 362 (SE 83) mg/l (median 435 mg/l, range 31 to 645 mg/l). The highest SAA value was attained, on average, 67 hours (range 51 to 74 hours) after the onset of chest pain but increased concentrations were observed earlier (fig 2) . The temporal relation between the kinetics of the changes in SAA concentrations and in CK-MB isoenzyme activities in the 10 patients is summarised in fig 2. The highest CK-MB activity could be measured about 13 to 16 hours after the onset of chest pain and thus preceded the maximal increase in SAA concentrations by about two days. A weak positive correlation (r = 0-58, n = 10, NS) was found between the peak concentrations of SAA and the peak activity of CK-MB during myocardial infarction; the correlation was stronger between SAA concentrations and total CKactivity (r = 0 70; n = 10, p < 0 05).
The concentrations of apoA-I fluctuated during the period immediately after infarction (fig 3) . A decrease in the concentrations was, however, evident (figs 2 and 3). The mean concentrations werm lowest at 67 to 72 hours (31% reduction, 1 p < 0-01; 95% confidence interval 0-84-1 30 g/l) after the onset of infarct pain.
The concentration of apoB showed pronounced variation during the immediate period after infarction (fig 4) . A Analysis of the combined data showed an inverse correlation between the concentrations of SAA and the apolipoproteins A-I and B (fig 2) . This correlation was stronger between SAA and apoB (pooled data, n = 143, r = -041, p < 0.001) than between SAA and apoA-I (pooled data, n = 143, r = -027, p < 0-01). ApoA-I and apoB correlated positively with each other (pooled data, n = 143, r = 0 33, p < 0O001). There were, however, pronounced individual variations in the relation between SAA and apoproteins A-I and B during the course of myocardial infarction.
Discussion
These results show that acute myocardial infarction is associated with noticeable changes in the SAA, apoA-I, and apoB protein concentrations associated with high density lipoprotein. During the early phase of acute myocardial infarction an inverse relation was found between SAA and apoB concentrations and also, though weaker, between SAA and apoA-I concentrations. With respect to SAA, our results agree with those of two recent reports."'2'
The peak SAA concentration correlated with peak total CK activity, and, to a lesser degree, with CK-MB activity, which is a fairly good index of infarct size. 24 The mechanism of increase in SAA is therefore probably related to the injured myocardial tissue; cell damage and necrosis lead to the activation of monocytes/macrophages, which release soluble mediators, inducing the acute phase synthesis of SAA by the hepatocytes. Interleukin 1 has been identified as a mediator of SAA synthesis`8 but other factors may also have a role. '0 25 26 In an experimental model Morrow and associates showed 500-to 2000-fold increases in mRNA for SAA during the acute phase state,2728 and a recent study suggests that interleukin I directly modulates acute phase gene expression.9 Although the liver is the main site of the acute phase SAA synthesis,8 2728 the possibility of extrahepatic synthesis should also be considered.2"3'
In the circulation the bulk of SAA is associated with high density lipoprotein; more than 75% being associated with HDL3. During the acute phase, SAA becomes an important apolipoprotein of high density lipoprotein. When calculated as protein mass per particle, SAA may sometimes even become the major apoprotein of high density lipoprotein, which under normal conditions is apo A-I.'33233 The acquisition of apoSAA results in the displacement of apoA-I and apoA-II from the high density lipoprotein particles.32
There is some evidence that high density lipoprotein particles enriched with SAA are more rapidly catabolised than normal particles.' 16 Our results showing an inverse relation between the circulating concentrations of SAA and apoA-I are of interest in this regard and are in agreement with the findings of Avogaro et al, who showed reduced apoA-I concentrations during the early period after infarction.34 The decrease in apoA-I concentrations after infarction is probably due to reduced synthesis, but enhanced uptake from the circulation may also contribute.
Apolipoprotein B is found in low density lipoprotein, very low density lipoprotein, and chylomicrons. Most of the plasma apoB resides in low density lipoprotein and apoB is virtually the only low density lipoprotein apoprotein. Our results, showing a significant fall in circulating apoB concentration in the period immediately after infarct agree with the results of Avogaro et at4 and Ryder et al.Ì
n conclusion, our results show that myocardial infarction induces pronounced changes in the plasma concentrations of SAA, apoA-I, and apoB. Further studies are therefore needed to assess the clinical relevance of these findings and to evaluate whether measurements of SAA would be of help in the assessment of prognosis and in the recognition of complications in patients with acute myocardial infarction.
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